Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

My Reflections on Research Cuts

Christina D. Downey, MD  |  June 10, 2025

If you’re like me, you may be feeling a little disheartened lately. Seeing colleagues’ grant funding seemingly pulled for attempting to answer critical questions about how we address structural racism, climate change and socioeconomic inequities, for example, is more than heartbreaking, especially given how vital this research is for our patients with systemic lupus, rheumatoid arthritis and other chronic conditions.1-3 Between February and April 2025, 694 grants funded by the National Institutes of Health (NIH) were terminated, and further cuts—amounting to a 40% reduction in the NIH budget—have been proposed.

Christina Downey, MD, RhMSUS, CCD

Dr. Downey

The NIH isn’t the only target: The fiscal year 2026 budget proposes a 44% cut to the Centers for Disease Control & Prevention and a 55% cut to the National Science Foundation, among others.4

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

For decades, the U.S. has served as a beacon to the international scientific community. With these drastic cuts to scientific investment, the U.S. stands to lose not only immigrants considering careers in research, but also homegrown scientists.5 A poll of 1,608 U.S. researchers found that 75% are considering leaving the country in favor of Canada and Europe, where grant funding is stable. Cutting research also hurts the economy. A recent report showed that a 25% cut to public research funding would reduce the GDP by 3.8%, comparable to the Great Recession. A 50% reduction is estimated to make the average American $10,000 poorer and would significantly shrink government revenue.6

As the chair of the Government Affairs Committee for the past two-and-a-half years and a health policy advocate for the past 11 years, I can relate a bit to Sisyphus. However, there is hope to be found from coalitions of attorneys general, state-led lawsuits, legal action by individual universities and a groundswell of public support for research and the pursuit of scientific advancement.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

It can sometimes be difficult to overcome the pull toward a deep well of nihilism when considering the threats to the practice of rheumatology. Consider the ongoing cuts to the Physician Fee Schedule and increasing burnout driven by pharmacy benefit managers (PBMs), as well as deep cuts in research grant funding, the silver linings can be hard to find. However, I saw several recently in Washington, D.C., this May.

I met with attuned Congressional staffers who are fighting for Medicare sustainability, to reform harmful PBM practices and to preserve scientific research of all kinds. I also met with colleagues and patients from 26 different states who are energized and engaged in holding our leaders accountable. It’s easy to forget, but there are still true public servants in Washington, D.C., and many informed, passionate citizens who are committed to preserving what makes America great.

Page: 1 2 | Single Page
Share: 

Filed under:OpinionProfessional Topics Tagged with:ACR advocacyResearch Funding

Related Articles

    Speak Up: Ask Congress to Block Medicare Reimbursement Cuts

    October 22, 2021

    Rheumatologists may need to downsize and restrict patient care if Congress doesn’t act to block significant cuts to Medicare reimbursement rates totaling 9.75% in 2022.

    The 2019 ACR Award Winners & Distinguished Fellows

    December 18, 2019

    ATLANTA—Every year at its Annual Meeting, the ACR recognizes its members’ outstanding contributions to the field of rheumatology through an awards program. The ACR is proud to announce 20 award recipients for 2019, honored for their accomplishments as clinicians, instructors or researchers who have helped advance rheumatology, for their commitment to inspire others to enter…

    Cuts to NIH Funding Affect Programs and Careers

    November 1, 2011

    Medical schools tap philanthropic organizatinos and the VA for research dollars

    Pressures Intensify for Rheumatology Researchers

    May 12, 2025

    Many rheumatology researchers share concerns about the landscape for future opportunities, given recent pressures from the current presidential administration. These may make an already challenging environment even more difficult for academic physicians to successfully navigate. But many in the field will persevere despite obstacles, driven by the need to deepen understanding of these conditions and…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences